Surrozen Inc., a biotechnology company focused on developing targeted therapeutics for severe eye diseases, will participate in two upcoming healthcare investor conferences. The company will hold a fireside discussion at the 37th Annual Piper Sandler Healthcare Conference on December 2, 2025, at 6:30 AM Pacific Time, and a fireside chat at the 8th Annual Evercore Healthcare Conference on December 3, 2025, at 12:25 PM Pacific Time. Audio webcasts of both events will be available through the Investors section of the Surrozen website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Surrozen Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9591773-en) on November 25, 2025, and is solely responsible for the information contained therein.
Comments